R Todd Stravitz1, Caitlyn Ellerbe2, Valerie Durkalski2, Adrian Reuben3, Ton Lisman4, William M Lee5. 1. Section of Hepatology and Hume-Lee Transplant Center, Virginia Commonwealth University, Richmond, Virginia. Electronic address: Richard.Stravitz@VCUHealth.ORG. 2. Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina. 3. Division of Gastroenterology, Medical University of South Carolina, Charleston, South Carolina. 4. Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. 5. University of Texas, Southwestern Medical Center, Dallas, Texas.
Abstract
BACKGROUND & AIMS: Acute liver failure (ALF) is a syndrome characterized by an intense systemic inflammatory response (SIRS) and multi-organ system failure (MOSF). Platelet-derived microparticles increase in proportion to the severity of the SIRS and MOSF, and are associated with poor outcome. We investigated whether patients with ALF develop thrombocytopenia in proportion to the SIRS, MOSF, and poor outcome. METHODS: In a retrospective study, we collected data on the post-admission platelet counts of 1598 patients included in the ALF Study Group Registry from 1998 through October 2012. We investigated correlations between platelet counts and clinical features of ALF, laboratory test results, and outcomes. Of the patients studied, 752 (47%) survived without liver transplantation, 390 (24%) received liver transplants, and 517 (32%) died. RESULTS: In patients with SIRS, platelet counts decreased 2 to 7 days after admission, compared with patients without SIRS (P ≤ .001). Patients with abnormal levels of creatinine, phosphate, lactate, or bicarbonate had significantly lower platelet counts than patients with normal levels of these laboratory values (all P ≤ .001). The decrease in platelets during days 1 to 7 after admission was proportional to the grade of hepatic encephalopathy and requirement for vasopressor and renal replacement therapy. Although platelet numbers decreased after admission in the overall population, platelets were significantly lower 2 to 7 days after admission in patients with outcomes of death or liver transplantation than in patients who made spontaneous recoveries and survived. In contrast, international normalized ratios over time were not associated with SIRS, laboratory test results associated with poor outcomes, grade of hepatic encephalopathy, or requirement for renal replacement therapy. CONCLUSIONS: The development of thrombocytopenia in patients with ALF is associated with the development of MOSF and poor outcome. We speculate that SIRS-induced activation of platelets, yielding microparticles, results in clearance of platelet remnants and subsequent thrombocytopenia.
BACKGROUND & AIMS:Acute liver failure (ALF) is a syndrome characterized by an intense systemic inflammatory response (SIRS) and multi-organ system failure (MOSF). Platelet-derived microparticles increase in proportion to the severity of the SIRS and MOSF, and are associated with poor outcome. We investigated whether patients with ALF develop thrombocytopenia in proportion to the SIRS, MOSF, and poor outcome. METHODS: In a retrospective study, we collected data on the post-admission platelet counts of 1598 patients included in the ALF Study Group Registry from 1998 through October 2012. We investigated correlations between platelet counts and clinical features of ALF, laboratory test results, and outcomes. Of the patients studied, 752 (47%) survived without liver transplantation, 390 (24%) received liver transplants, and 517 (32%) died. RESULTS: In patients with SIRS, platelet counts decreased 2 to 7 days after admission, compared with patients without SIRS (P ≤ .001). Patients with abnormal levels of creatinine, phosphate, lactate, or bicarbonate had significantly lower platelet counts than patients with normal levels of these laboratory values (all P ≤ .001). The decrease in platelets during days 1 to 7 after admission was proportional to the grade of hepatic encephalopathy and requirement for vasopressor and renal replacement therapy. Although platelet numbers decreased after admission in the overall population, platelets were significantly lower 2 to 7 days after admission in patients with outcomes of death or liver transplantation than in patients who made spontaneous recoveries and survived. In contrast, international normalized ratios over time were not associated with SIRS, laboratory test results associated with poor outcomes, grade of hepatic encephalopathy, or requirement for renal replacement therapy. CONCLUSIONS: The development of thrombocytopenia in patients with ALF is associated with the development of MOSF and poor outcome. We speculate that SIRS-induced activation of platelets, yielding microparticles, results in clearance of platelet remnants and subsequent thrombocytopenia.
Authors: Kazuhisa Miyakawa; Nikita Joshi; Bradley P Sullivan; Ryan Albee; Christina Brandenberger; Hartmut Jaeschke; Mitchell R McGill; Michael A Scott; Patricia E Ganey; James P Luyendyk; Robert A Roth Journal: Blood Date: 2015-07-15 Impact factor: 22.113
Authors: Sujith V W Weerasinghe; David S Moons; Peter J Altshuler; Yatrik M Shah; M Bishr Omary Journal: Hepatology Date: 2011-04 Impact factor: 17.425
Authors: R Todd Stravitz; Ton Lisman; Velimir A Luketic; Richard K Sterling; Puneet Puri; Michael Fuchs; Ashraf Ibrahim; William M Lee; Arun J Sanyal Journal: J Hepatol Date: 2011-05-19 Impact factor: 25.083
Authors: Greg C G Hugenholtz; Jelle Adelmeijer; Joost C M Meijers; Robert J Porte; R Todd Stravitz; Ton Lisman Journal: Hepatology Date: 2013-07-01 Impact factor: 17.425
Authors: Paul H Hayashi; Don C Rockey; Robert J Fontana; Hans L Tillmann; Neil Kaplowitz; Huiman X Barnhart; Jiezhan Gu; Naga P Chalasani; K Rajender Reddy; Averell H Sherker; Jay H Hoofnagle Journal: Hepatology Date: 2017-08-26 Impact factor: 17.425
Authors: Brian C Davis; Holly Tillman; Raymond T Chung; Richard T Stravitz; Rajender Reddy; Robert J Fontana; Brendan McGuire; Timothy Davern; William M Lee Journal: Liver Int Date: 2017-02-17 Impact factor: 5.828
Authors: R Todd Stravitz; Caitlyn Ellerbe; Valerie Durkalski; Michael Schilsky; Robert J Fontana; Carolyn Peterseim; William M Lee Journal: Hepatology Date: 2018-03-26 Impact factor: 17.425
Authors: Dafna Groeneveld; Holly Cline-Fedewa; Kevin S Baker; Kurt J Williams; Robert A Roth; Karen Mittermeier; Ton Lisman; Joseph S Palumbo; James P Luyendyk Journal: J Hepatol Date: 2019-10-10 Impact factor: 30.083
Authors: Zhao Shan; Leike Li; Constance Lynn Atkins; Meng Wang; Yankai Wen; Jongmin Jeong; Nicolas F Moreno; Dechun Feng; Xun Gui; Ningyan Zhang; Chun Geun Lee; Jack A Elias; William M Lee; Bin Gao; Fong Wilson Lam; Zhiqiang An; Cynthia Ju Journal: Elife Date: 2021-06-10 Impact factor: 8.140
Authors: Ellen G Driever; R Todd Stravitz; Jingwen Zhang; Jelle Adelmeijer; Valerie Durkalski; William M Lee; Ton Lisman Journal: Hepatology Date: 2021-05 Impact factor: 17.425